Complete the pivotal efficacy study for the KIND-030 treatment indication
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- 2 Jun 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Completion of the upcoming pivotal efficacy study for the treatment indication for KIND-030 is now expected to extend into the second quarter of 2021.”
What we found
Evidence strength A What the grades mean
A later 10-Q reports that positive results from the pivotal efficacy study in parvovirus-infected dogs were announced on June 2, 2021, before the June 30, 2021 deadline.
-
A Kindred Biosciences, Inc. 10-Q filed 2021-08-05
“On June 2, 2021 we announced positive results from a pivotal efficacy study of KIND-030 in dogs infected by parvovirus.” ✓ confirmed on the page
-
A Kindred Biosciences, Inc. 10-Q filed 2021-08-05
“Results of the pivotal efficacy study for the treatment of established parvovirus infection were filed with the United States Department of Agriculture in June 2021.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- Pivotal efficacy study for KIND-030 treatment indication
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Kindred Biosciences, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C561743-024612 · Corrections policy